Literature DB >> 8461540

Binding of osteopontin to the osteoclast integrin alpha v beta 3.

A Miyauchi1, J Alvarez, E M Greenfield, A Teti, M Grano, S Colucci, A Zambonin-Zallone, F P Ross, S L Teitelbaum, D Cheresh.   

Abstract

Occupancy of the chicken osteoclast alpha v beta 3 integrin stimulates immediate cell signals. Peptides from osteopontin containing Arg-Gly-Asp and peptides from the osteopontin and bone sialoprotein sequences containing Arg-Gly-Asp stimulated immediate reductions in osteoclast cytosolic Ca2+. The changes in cytosolic Ca2+ required the Arg-Gly-Asp sequence, and were blocked by LM609, a monoclonal antibody to the alpha v beta 3 integrin. Osteoclast stimulation by the proteins through the integrin did not require immobilization since soluble peptides produced changes in cytosolic Ca2+ and inhibited osteoclast binding to bone particles and bone resorption. The decrease in cytosolic Ca2+ stimulated by osteopontin and related peptides was due to activation of a plasma membrane Ca(2+)-ATPase. Thus, the data suggest that ligand binding to the osteoclast alpha v beta 3 integrin results in a reduction in cytosolic Ca2+ which participates in regulation of osteoclast function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461540     DOI: 10.1007/bf01621887

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  18 in total

1.  Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130-kDa alpha subunit.

Authors:  D A Cheresh; J R Harper
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

2.  Spontaneous [Ca2+]i fluctuations in rat chromaffin cells do not require inositol 1,4,5-trisphosphate elevations but are generated by a caffeine- and ryanodine-sensitive intracellular Ca2+ store.

Authors:  A Malgaroli; R Fesce; J Meldolesi
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

3.  Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions.

Authors:  P C Marchisio; D Cirillo; A Teti; A Zambonin-Zallone; G Tarone
Journal:  Exp Cell Res       Date:  1987-03       Impact factor: 3.905

4.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Extracellular protons acidify osteoclasts, reduce cytosolic calcium, and promote expression of cell-matrix attachment structures.

Authors:  A Teti; H C Blair; P Schlesinger; M Grano; A Zambonin-Zallone; A J Kahn; S L Teitelbaum; K A Hruska
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

6.  Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane.

Authors:  H Takemura; A R Hughes; O Thastrup; J W Putney
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

7.  The osteoclast: review of ultrastructure, origin, and structure-function relationship.

Authors:  G Göthlin; J L Ericsson
Journal:  Clin Orthop Relat Res       Date:  1976-10       Impact factor: 4.176

8.  Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures.

Authors:  P C Marchisio; D Cirillo; L Naldini; M V Primavera; A Teti; A Zambonin-Zallone
Journal:  J Cell Biol       Date:  1984-11       Impact factor: 10.539

9.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.

Authors:  J Davies; J Warwick; N Totty; R Philp; M Helfrich; M Horton
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

10.  Integrin heterodimer and receptor complexity in avian and mammalian cells.

Authors:  R O Hynes; E E Marcantonio; M A Stepp; L A Urry; G H Yee
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  9 in total

1.  Microcracks and osteoclast resorption activity in vitro.

Authors:  Monika Rumpler; Tanja Würger; Paul Roschger; Elisabeth Zwettler; Herwig Peterlik; Peter Fratzl; Klaus Klaushofer
Journal:  Calcif Tissue Int       Date:  2012-01-24       Impact factor: 4.333

2.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

3.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

4.  TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.

Authors:  Estelle Chamoux; Martine Bisson; Marcel Daniel Payet; Sophie Roux
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

5.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

6.  Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.

Authors:  Mansoor Ahmed; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-05-07       Impact factor: 27.401

7.  [Biochemical bone resorption markers during the healing of osteoporotic fractures].

Authors:  C Heiss; L M Hoesel; M Pausch; S A Meissner; U Horas; O Kilian; U Wehr; W A Rambeck; R Schnettler
Journal:  Unfallchirurg       Date:  2008-09       Impact factor: 1.000

8.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Authors:  M P Lisanti; P E Scherer; J Vidugiriene; Z Tang; A Hermanowski-Vosatka; Y H Tu; R F Cook; M Sargiacomo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis.

Authors:  Yuye Zhou; Joakim Romson; Åsa Emmer
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.